Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails

Study Description

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

This study's purpose is to prospectively determine whether topical therapy with an oxidized regenerated cellulose collagen-silver compound is more effective than the current standard of topical antibiotic therapy for care following the removal of an ingrown toenail. Eighty adult patients with ingrown toenails will be recruited. Each patient will randomly be assigned to apply either topical silver sulfadiazine cream (standard antibiotic) or the novel collagen-silver compound to their nail bed daily, following removal of the ingrown portion of nail. Patients will return for follow up visits weekly, until healing has occurred or twelve weeks have passed. Healing will be defined as resolution of drainage and inflammatory changes surrounding the nail border.

Condition or disease	Intervention/treatment	Phase
Ingrown Nail	Device: oxidized regenerated cellulose collagen-silver; Drug: topical silver sulfadiazine cream	Not Applicable

Study Design

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	80 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Masking:	Single (Outcomes Assessor)
Primary Purpose:	Treatment
Official Title:	Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial
Study Start Date :	November 2005
Estimated Primary Completion Date :	May 2008
Estimated Study Completion Date :	May 2008

Arms and Interventions

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm	Intervention/treatment
Experimental: experimental; Subjects will daily dress their nail bed with oxidized regenerated cellulose collagen-silver, until healing occurs.	Device: oxidized regenerated cellulose collagen-silver; Wound dressed daily with oxidized regenerated cellulose collagen-silver matrix.; Other Name: Prisma
Active Comparator: Control; Topical silver sulfadiazine cream will be applied daily to the wound bed until healing has occured.	Drug: topical silver sulfadiazine cream; Cream will be applied to nailbed daily and dressed with a bandage until healing occurs.; Other Name: Silvadene, Thermazene

Outcome Measures

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. time to healing [ Time Frame: weekly ]

Secondary Outcome Measures :

1. time to return to regular shoe gear [ Time Frame: weekly ]
2. days unable to work [ Time Frame: weekly ]

Eligibility Criteria

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

• Ingrown toenails will be defined as any incurvated nail border that digs into the skin of the nail fold and causes pain and discomfort

Exclusion Criteria:

• Patients with immunocompromised states

  • chronic steroid use
  • diabetes mellitus
  • collagen vascular disease
  • HIV infection
• Cellulitis proximal to the hallux interphalangeal joint or peripheral vascular disease will be excluded
• We will define peripheral vascular disease as the absence of one or more pedal pulses or the presence of dystrophic changes to the integument

Contacts and Locations

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Contacts

Contact: David G Armstrong, DPM, PhD	847-578-8440	david.armstrong@rosalindfranklin.edu

Locations

United States, Illinois
Scholl Foot and Ankle Center	Recruiting
North Chicago, Illinois, United States, 60064
Contact: Ryan T Crews, MS 847-578-8437 ryan.crews@rosalindfranklin.edu
Principal Investigator: David Armstrong, DPM, PhD
Sub-Investigator: Stephanie Wu, DPM, MS
Sub-Investigator: James Wrobel, DPM, MS
United States, Virginia
Preofessional Education and Research Institutue	Recruiting
Roanoke, Virginia, United States, 24016
Contact: Charles Zelen, DPM 540-725-5027 cmzelen@periedu.com
Principal Investigator: Charles Zelen, DPM

Sponsors and Collaborators

Rosalind Franklin University of Medicine and Science

Investigators

Principal Investigator:	David G Armstrong, DPM, PhD	Rosalind Franklin University

More Information

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party:	Office of Sponsored Research, Rosalind Franklin University of Medicine and Science
ClinicalTrials.gov Identifier:	NCT00641433 History of Changes
Other Study ID Numbers:	ORT 014
First Posted:	March 24, 2008
Last Update Posted:	March 24, 2008
Last Verified:	March 2008

Keywords provided by Rosalind Franklin University of Medicine and Science:

chemocautery

Additional relevant MeSH terms:

Nails, Ingrown; Nail Diseases; Skin Diseases; Sulfadiazine; Silver Sulfadiazine	Anti-Infective Agents; Antiprotozoal Agents; Antiparasitic Agents; Coccidiostats; Anti-Infective Agents, Local